JPS6043345B2 - フェノチアジン誘導体及びそれらの製造方法 - Google Patents

フェノチアジン誘導体及びそれらの製造方法

Info

Publication number: JPS6043345B2
Authority: JP; Japan
Prior art keywords: tables; formulas; formula; phenothiazine; chemical formulas
Prior art date: 1979-04-06
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired

Application number

JP55044086A

Other languages

English (en)

Japanese (ja)

Other versions

JPS55153776A (en

Inventor

ライオス・トルデイイ

イストバン・トタ

イルデイコ・キラルイ

ヨセフ・ボルスイ

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Egyt Gyogyszervegyeszeti Gyar

Original Assignee

Egyt Gyogyszervegyeszeti Gyar

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1979-04-06

Filing date

1980-04-05

Publication date

1985-09-27

1980-04-05 Application filed by Egyt Gyogyszervegyeszeti Gyar filed Critical Egyt Gyogyszervegyeszeti Gyar

1980-11-29 Publication of JPS55153776A publication Critical patent/JPS55153776A/ja

1985-09-27 Publication of JPS6043345B2 publication Critical patent/JPS6043345B2/ja

Status Expired legal-status Critical Current

Links

238000000034 method Methods 0.000 title claims description 25
229940066767 systemic antihistamines phenothiazine derivative Drugs 0.000 title claims description 5
125000001484 phenothiazinyl group Chemical class C1(=CC=CC=2SC3=CC=CC=C3NC12)* 0.000 title description 2
239000002253 acid Substances 0.000 claims description 39
150000003839 salts Chemical class 0.000 claims description 30
150000002148 esters Chemical class 0.000 claims description 28
239000000126 substance Substances 0.000 claims description 17
150000002990 phenothiazines Chemical class 0.000 claims description 9
229910052739 hydrogen Inorganic materials 0.000 claims description 6
239000001257 hydrogen Substances 0.000 claims description 6
125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 6
125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 6
125000001424 substituent group Chemical group 0.000 claims description 6
150000001735 carboxylic acids Chemical class 0.000 claims description 5
125000005843 halogen group Chemical group 0.000 claims description 5
239000007788 liquid Substances 0.000 claims description 5
229950000688 phenothiazine Drugs 0.000 claims description 5
239000004480 active ingredient Substances 0.000 claims description 4
125000003118 aryl group Chemical group 0.000 claims description 4
ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical group [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 3
125000000217 alkyl group Chemical group 0.000 claims description 3
239000000460 chlorine Chemical group 0.000 claims description 3
229910052801 chlorine Inorganic materials 0.000 claims description 3
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 3
239000007787 solid Substances 0.000 claims description 3
125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 3
125000004178 (C1-C4) alkyl group Chemical group 0.000 claims description 2
239000003937 drug carrier Substances 0.000 claims description 2
239000012458 free base Substances 0.000 claims description 2
238000004519 manufacturing process Methods 0.000 claims 2
UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 27
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 27
150000001875 compounds Chemical class 0.000 description 18
238000002844 melting Methods 0.000 description 18
230000008018 melting Effects 0.000 description 18
239000000243 solution Substances 0.000 description 18
-1 ethanesulfonate Chemical class 0.000 description 14
238000002360 preparation method Methods 0.000 description 14
VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 13
239000002585 base Substances 0.000 description 13
HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 12
PLDUPXSUYLZYBN-UHFFFAOYSA-N Fluphenazine Chemical compound C1CN(CCO)CCN1CCCN1C2=CC(C(F)(F)F)=CC=C2SC2=CC=CC=C21 PLDUPXSUYLZYBN-UHFFFAOYSA-N 0.000 description 12
238000001953 recrystallisation Methods 0.000 description 12
239000000203 mixture Substances 0.000 description 11
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 10
FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 10
230000000694 effects Effects 0.000 description 8
229960002690 fluphenazine Drugs 0.000 description 8
239000007858 starting material Substances 0.000 description 8
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 7
150000001263 acyl chlorides Chemical class 0.000 description 7
OSDLLIBGSJNGJE-UHFFFAOYSA-N 4-chloro-3,5-dimethylphenol Chemical compound CC1=CC(O)=CC(C)=C1Cl OSDLLIBGSJNGJE-UHFFFAOYSA-N 0.000 description 5
230000004071 biological effect Effects 0.000 description 5
238000009835 boiling Methods 0.000 description 5
239000008194 pharmaceutical composition Substances 0.000 description 5
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 4
CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 4
UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
229940079593 drug Drugs 0.000 description 4
239000003814 drug Substances 0.000 description 4
VIQCGTZFEYDQMR-UHFFFAOYSA-N fluphenazine decanoate Chemical compound C1CN(CCOC(=O)CCCCCCCCC)CCN1CCCN1C2=CC(C(F)(F)F)=CC=C2SC2=CC=CC=C21 VIQCGTZFEYDQMR-UHFFFAOYSA-N 0.000 description 4
229960001374 fluphenazine decanoate Drugs 0.000 description 4
239000008159 sesame oil Substances 0.000 description 4
235000011803 sesame oil Nutrition 0.000 description 4
KTZYBQFUJLPFMF-UHFFFAOYSA-N 2-(3,5-dimethylphenoxy)-2-methylpropanoyl chloride Chemical compound CC1=CC(C)=CC(OC(C)(C)C(Cl)=O)=C1 KTZYBQFUJLPFMF-UHFFFAOYSA-N 0.000 description 3
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 3
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
150000007513 acids Chemical class 0.000 description 3
150000001732 carboxylic acid derivatives Chemical class 0.000 description 3
238000002347 injection Methods 0.000 description 3
239000007924 injection Substances 0.000 description 3
229910052938 sodium sulfate Inorganic materials 0.000 description 3
235000011152 sodium sulphate Nutrition 0.000 description 3
230000002459 sustained effect Effects 0.000 description 3
239000006188 syrup Substances 0.000 description 3
235000020357 syrup Nutrition 0.000 description 3
VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 3
OBTBTAXSGBQRGI-UHFFFAOYSA-N 2-(2,6-dichlorophenoxy)-2-methylpropanoic acid Chemical compound OC(=O)C(C)(C)OC1=C(Cl)C=CC=C1Cl OBTBTAXSGBQRGI-UHFFFAOYSA-N 0.000 description 2
SXWGTMNDGSAUON-UHFFFAOYSA-N 2-(3,5-dimethylphenoxy)-2-methylpropanoic acid Chemical class CC1=CC(C)=CC(OC(C)(C)C(O)=O)=C1 SXWGTMNDGSAUON-UHFFFAOYSA-N 0.000 description 2
NAABUGJBFBVHMI-UHFFFAOYSA-N 2-(4-tert-butylphenoxy)-2-methylpropanoyl chloride Chemical compound CC(C)(C)C1=CC=C(OC(C)(C)C(Cl)=O)C=C1 NAABUGJBFBVHMI-UHFFFAOYSA-N 0.000 description 2
SJSOFNCYXJUNBT-UHFFFAOYSA-N 3,4,5-trimethoxybenzoic acid Chemical compound COC1=CC(C(O)=O)=CC(OC)=C1OC SJSOFNCYXJUNBT-UHFFFAOYSA-N 0.000 description 2
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
206010047700 Vomiting Diseases 0.000 description 2
JIMXXGFJRDUSRO-UHFFFAOYSA-N adamantane-1-carboxylic acid Chemical compound C1C(C2)CC3CC2CC1(C(=O)O)C3 JIMXXGFJRDUSRO-UHFFFAOYSA-N 0.000 description 2
229910052783 alkali metal Inorganic materials 0.000 description 2
VMWNQDUVQKEIOC-CYBMUJFWSA-N apomorphine Chemical compound C([C@H]1N(C)CC2)C3=CC=C(O)C(O)=C3C3=C1C2=CC=C3 VMWNQDUVQKEIOC-CYBMUJFWSA-N 0.000 description 2
229960004046 apomorphine Drugs 0.000 description 2
239000007864 aqueous solution Substances 0.000 description 2
239000002775 capsule Substances 0.000 description 2
230000001143 conditioned effect Effects 0.000 description 2
239000012043 crude product Substances 0.000 description 2
239000013078 crystal Substances 0.000 description 2
230000032050 esterification Effects 0.000 description 2
238000005886 esterification reaction Methods 0.000 description 2
150000003840 hydrochlorides Chemical class 0.000 description 2
230000006742 locomotor activity Effects 0.000 description 2
HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
239000003921 oil Substances 0.000 description 2
235000019198 oils Nutrition 0.000 description 2
239000012074 organic phase Substances 0.000 description 2
239000000047 product Substances 0.000 description 2
238000000746 purification Methods 0.000 description 2
238000010992 reflux Methods 0.000 description 2
230000004044 response Effects 0.000 description 2
229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
235000017557 sodium bicarbonate Nutrition 0.000 description 2
239000000829 suppository Substances 0.000 description 2
CVHZOJJKTDOEJC-UHFFFAOYSA-M 1,1-dioxo-1,2-benzothiazol-3-olate Chemical compound C1=CC=C2C([O-])=NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-M 0.000 description 1
WJFKNYWRSNBZNX-UHFFFAOYSA-N 10H-phenothiazine Chemical compound C1=CC=C2NC3=CC=CC=C3SC2=C1 WJFKNYWRSNBZNX-UHFFFAOYSA-N 0.000 description 1
ZAWKYPLLOTZOCX-UHFFFAOYSA-N 2,3-dimethyl-2-naphthalen-1-yloxybutanoic acid Chemical compound C1=CC=C2C(OC(C)(C(C)C)C(O)=O)=CC=CC2=C1 ZAWKYPLLOTZOCX-UHFFFAOYSA-N 0.000 description 1
WYFSUSLTCPKAEY-UHFFFAOYSA-N 2,3-dimethyl-2-phenoxybutanoic acid Chemical compound CC(C)C(C)(C(O)=O)OC1=CC=CC=C1 WYFSUSLTCPKAEY-UHFFFAOYSA-N 0.000 description 1
IHAQERCVADRQLM-UHFFFAOYSA-N 2-(2,3-dichlorophenoxy)-2-methylpropanoic acid Chemical compound OC(=O)C(C)(C)OC1=CC=CC(Cl)=C1Cl IHAQERCVADRQLM-UHFFFAOYSA-N 0.000 description 1
JXYZSUYTZSGVQE-UHFFFAOYSA-N 2-(2,3-dichlorophenoxy)-2-methylpropanoyl chloride Chemical compound ClC(=O)C(C)(C)OC1=CC=CC(Cl)=C1Cl JXYZSUYTZSGVQE-UHFFFAOYSA-N 0.000 description 1
UHNQBMHNYDFJKX-UHFFFAOYSA-N 2-(2,5-dimethylphenoxy)-2-methylpropanoic acid Chemical compound CC1=CC=C(C)C(OC(C)(C)C(O)=O)=C1 UHNQBMHNYDFJKX-UHFFFAOYSA-N 0.000 description 1
NKOLBXHNFWSMHI-UHFFFAOYSA-N 2-(2,5-dimethylphenoxy)-2-methylpropanoyl chloride Chemical compound CC1=CC=C(C)C(OC(C)(C)C(Cl)=O)=C1 NKOLBXHNFWSMHI-UHFFFAOYSA-N 0.000 description 1
KMJGWRUNLSTING-UHFFFAOYSA-N 2-(2,6-dichlorophenoxy)-2-methylpropanoyl chloride Chemical compound ClC(=O)C(C)(C)OC1=C(Cl)C=CC=C1Cl KMJGWRUNLSTING-UHFFFAOYSA-N 0.000 description 1
KPYUGMQZJXMMOM-UHFFFAOYSA-N 2-(2,6-dimethylphenoxy)-2-methylpropanoic acid Chemical compound CC1=CC=CC(C)=C1OC(C)(C)C(O)=O KPYUGMQZJXMMOM-UHFFFAOYSA-N 0.000 description 1
UXDMCAHPVYEHKH-UHFFFAOYSA-N 2-(2,6-dimethylphenoxy)-2-methylpropanoyl chloride Chemical compound CC1=CC=CC(C)=C1OC(C)(C)C(Cl)=O UXDMCAHPVYEHKH-UHFFFAOYSA-N 0.000 description 1
OODRWLGKUBMFLZ-UHFFFAOYSA-N 2-(4-chlorophenoxy)-2-methylpropanoyl chloride Chemical compound ClC(=O)C(C)(C)OC1=CC=C(Cl)C=C1 OODRWLGKUBMFLZ-UHFFFAOYSA-N 0.000 description 1
CMWTZPSULFXXJA-UHFFFAOYSA-N 2-(6-methoxy-2-naphthalenyl)propanoic acid Chemical compound C1=C(C(C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-UHFFFAOYSA-N 0.000 description 1
UODROGXCIVAQDJ-UHFFFAOYSA-N 2-(6-methoxynaphthalen-2-yl)propanoyl chloride Chemical compound C1=C(C(C)C(Cl)=O)C=CC2=CC(OC)=CC=C21 UODROGXCIVAQDJ-UHFFFAOYSA-N 0.000 description 1
125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 1
RZDVBMXTYNFTJD-UHFFFAOYSA-N 2-methyl-2-(2,4,6-trimethylphenoxy)propanoic acid Chemical compound CC1=CC(C)=C(OC(C)(C)C(O)=O)C(C)=C1 RZDVBMXTYNFTJD-UHFFFAOYSA-N 0.000 description 1
ZGQMZVWPCVHENS-UHFFFAOYSA-N 2-methyl-2-(4-nitrophenoxy)propanoic acid Chemical compound OC(=O)C(C)(C)OC1=CC=C([N+]([O-])=O)C=C1 ZGQMZVWPCVHENS-UHFFFAOYSA-N 0.000 description 1
FEQKLTOBQAFPHM-UHFFFAOYSA-N 2-methyl-2-(4-nitrophenoxy)propanoyl chloride Chemical compound ClC(=O)C(C)(C)OC1=CC=C([N+]([O-])=O)C=C1 FEQKLTOBQAFPHM-UHFFFAOYSA-N 0.000 description 1
DZCPSVQCXLAEKZ-UHFFFAOYSA-N 2-methyl-2-naphthalen-1-yloxypropanoyl chloride Chemical compound C1=CC=C2C(OC(C)(C)C(Cl)=O)=CC=CC2=C1 DZCPSVQCXLAEKZ-UHFFFAOYSA-N 0.000 description 1
RVAWSQIHNATWNO-UHFFFAOYSA-N 2-methyl-2-naphthalen-2-yloxypropanoic acid Chemical compound C1=CC=CC2=CC(OC(C)(C)C(O)=O)=CC=C21 RVAWSQIHNATWNO-UHFFFAOYSA-N 0.000 description 1
ILPUOPPYSQEBNJ-UHFFFAOYSA-N 2-methyl-2-phenoxypropanoic acid Chemical compound OC(=O)C(C)(C)OC1=CC=CC=C1 ILPUOPPYSQEBNJ-UHFFFAOYSA-N 0.000 description 1
WWIJGHHDQFJHQW-UHFFFAOYSA-N 2-methyl-2-phenoxypropanoyl chloride Chemical compound ClC(=O)C(C)(C)OC1=CC=CC=C1 WWIJGHHDQFJHQW-UHFFFAOYSA-N 0.000 description 1
QORUPYXZMNXIAS-UHFFFAOYSA-N 3,3-dichloro-2-methyl-2-phenoxypropanoic acid Chemical compound ClC(Cl)C(C(O)=O)(C)OC1=CC=CC=C1 QORUPYXZMNXIAS-UHFFFAOYSA-N 0.000 description 1
IWPZKOJSYQZABD-UHFFFAOYSA-N 3,4,5-trimethoxybenzoic acid Natural products COC1=CC(OC)=CC(C(O)=O)=C1 IWPZKOJSYQZABD-UHFFFAOYSA-N 0.000 description 1
SCWBSTVOWDDYHH-UHFFFAOYSA-N 4-amino-2,6-dichlorophenol;4-aminophenol Chemical compound NC1=CC=C(O)C=C1.NC1=CC(Cl)=C(O)C(Cl)=C1 SCWBSTVOWDDYHH-UHFFFAOYSA-N 0.000 description 1
ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Natural products CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 1
MEPKRIDFXPYSMP-UHFFFAOYSA-N CCC(C(=O)O)(C)OC1=CC=CC2=CC=CC=C12 Chemical compound CCC(C(=O)O)(C)OC1=CC=CC2=CC=CC=C12 MEPKRIDFXPYSMP-UHFFFAOYSA-N 0.000 description 1
241000282472 Canis lupus familiaris Species 0.000 description 1
208000009132 Catalepsy Diseases 0.000 description 1
KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
RGHNJXZEOKUKBD-SQOUGZDYSA-M D-gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O RGHNJXZEOKUKBD-SQOUGZDYSA-M 0.000 description 1
FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
108010010803 Gelatin Proteins 0.000 description 1
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
229930195725 Mannitol Natural products 0.000 description 1
241001465754 Metazoa Species 0.000 description 1
229910019142 PO4 Inorganic materials 0.000 description 1
235000019483 Peanut oil Nutrition 0.000 description 1
229920002472 Starch Polymers 0.000 description 1
206010047853 Waxy flexibility Diseases 0.000 description 1
150000008065 acid anhydrides Chemical class 0.000 description 1
239000013543 active substance Substances 0.000 description 1
150000003855 acyl compounds Chemical class 0.000 description 1
150000001266 acyl halides Chemical class 0.000 description 1
230000003444 anaesthetic effect Effects 0.000 description 1
230000008485 antagonism Effects 0.000 description 1
150000001540 azides Chemical class 0.000 description 1
230000009286 beneficial effect Effects 0.000 description 1
GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
229910052794 bromium Inorganic materials 0.000 description 1
239000011575 calcium Substances 0.000 description 1
229910052791 calcium Inorganic materials 0.000 description 1
239000000969 carrier Substances 0.000 description 1
239000001913 cellulose Substances 0.000 description 1
229920002678 cellulose Polymers 0.000 description 1
235000010980 cellulose Nutrition 0.000 description 1
239000003795 chemical substances by application Substances 0.000 description 1
150000001805 chlorine compounds Chemical class 0.000 description 1
229940001468 citrate Drugs 0.000 description 1
TXCGAZHTZHNUAI-UHFFFAOYSA-N clofibric acid Chemical compound OC(=O)C(C)(C)OC1=CC=C(Cl)C=C1 TXCGAZHTZHNUAI-UHFFFAOYSA-N 0.000 description 1
IQFVPQOLBLOTPF-HKXUKFGYSA-L congo red Chemical compound [Na+].[Na+].C1=CC=CC2=C(N)C(/N=N/C3=CC=C(C=C3)C3=CC=C(C=C3)/N=N/C3=C(C4=CC=CC=C4C(=C3)S([O-])(=O)=O)N)=CC(S([O-])(=O)=O)=C21 IQFVPQOLBLOTPF-HKXUKFGYSA-L 0.000 description 1
238000001816 cooling Methods 0.000 description 1
230000003247 decreasing effect Effects 0.000 description 1
235000014113 dietary fatty acids Nutrition 0.000 description 1
239000002552 dosage form Substances 0.000 description 1
CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 description 1
125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
239000000194 fatty acid Substances 0.000 description 1
229930195729 fatty acid Natural products 0.000 description 1
150000004665 fatty acids Chemical class 0.000 description 1
230000002349 favourable effect Effects 0.000 description 1
229910052731 fluorine Inorganic materials 0.000 description 1
239000011737 fluorine Substances 0.000 description 1
VZCYOOQTPOCHFL-OWOJBTEDSA-L fumarate(2-) Chemical class [O-]C(=O)\C=C\C([O-])=O VZCYOOQTPOCHFL-OWOJBTEDSA-L 0.000 description 1
239000001530 fumaric acid Substances 0.000 description 1
239000008273 gelatin Substances 0.000 description 1
229920000159 gelatin Polymers 0.000 description 1
235000019322 gelatine Nutrition 0.000 description 1
235000011852 gelatine desserts Nutrition 0.000 description 1
229940050410 gluconate Drugs 0.000 description 1
239000008241 heterogeneous mixture Substances 0.000 description 1
239000005457 ice water Substances 0.000 description 1
230000001939 inductive effect Effects 0.000 description 1
239000012442 inert solvent Substances 0.000 description 1
239000007972 injectable composition Substances 0.000 description 1
229910052500 inorganic mineral Inorganic materials 0.000 description 1
239000011630 iodine Substances 0.000 description 1
229910052740 iodine Inorganic materials 0.000 description 1
125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
235000019359 magnesium stearate Nutrition 0.000 description 1
VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
239000000594 mannitol Substances 0.000 description 1
235000010355 mannitol Nutrition 0.000 description 1
239000011707 mineral Substances 0.000 description 1
235000010755 mineral Nutrition 0.000 description 1
125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
FRXPDEZCWCPLIH-UHFFFAOYSA-N naphthalen-1-yl propanoate Chemical class C1=CC=C2C(OC(=O)CC)=CC=CC2=C1 FRXPDEZCWCPLIH-UHFFFAOYSA-N 0.000 description 1
150000004780 naphthols Chemical class 0.000 description 1
230000001508 neuroinhibitory effect Effects 0.000 description 1
231100000252 nontoxic Toxicity 0.000 description 1
230000003000 nontoxic effect Effects 0.000 description 1
150000007524 organic acids Chemical class 0.000 description 1
235000005985 organic acids Nutrition 0.000 description 1
239000012044 organic layer Substances 0.000 description 1
239000000312 peanut oil Substances 0.000 description 1
239000008188 pellet Substances 0.000 description 1
239000003208 petroleum Substances 0.000 description 1
239000000825 pharmaceutical preparation Substances 0.000 description 1
150000002989 phenols Chemical class 0.000 description 1
WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
235000021317 phosphate Nutrition 0.000 description 1
150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
159000000001 potassium salts Chemical class 0.000 description 1
230000003389 potentiating effect Effects 0.000 description 1
239000000843 powder Substances 0.000 description 1
150000003151 propanoic acid esters Chemical class 0.000 description 1
239000011541 reaction mixture Substances 0.000 description 1
239000011734 sodium Substances 0.000 description 1
229910052708 sodium Inorganic materials 0.000 description 1
159000000000 sodium salts Chemical class 0.000 description 1
239000008107 starch Substances 0.000 description 1
235000019698 starch Nutrition 0.000 description 1
238000003756 stirring Methods 0.000 description 1
229940086735 succinate Drugs 0.000 description 1
KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
230000001629 suppression Effects 0.000 description 1
239000000725 suspension Substances 0.000 description 1
239000000454 talc Substances 0.000 description 1
229910052623 talc Inorganic materials 0.000 description 1
235000012222 talc Nutrition 0.000 description 1
229940095064 tartrate Drugs 0.000 description 1
230000001225 therapeutic effect Effects 0.000 description 1
231100000419 toxicity Toxicity 0.000 description 1
230000001988 toxicity Effects 0.000 description 1
ILWRPSCZWQJDMK-UHFFFAOYSA-N triethylazanium;chloride Chemical compound Cl.CCN(CC)CC ILWRPSCZWQJDMK-UHFFFAOYSA-N 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
- C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
- C07D279/18—[b, e]-condensed with two six-membered rings
- C07D279/22—[b, e]-condensed with two six-membered rings with carbon atoms directly attached to the ring nitrogen atom
- C07D279/24—[b, e]-condensed with two six-membered rings with carbon atoms directly attached to the ring nitrogen atom with hydrocarbon radicals, substituted by amino radicals, attached to the ring nitrogen atom
- C07D279/28—[b, e]-condensed with two six-membered rings with carbon atoms directly attached to the ring nitrogen atom with hydrocarbon radicals, substituted by amino radicals, attached to the ring nitrogen atom with other substituents attached to the ring system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Hospice & Palliative Care (AREA)
Otolaryngology (AREA)
Psychiatry (AREA)
Anesthesiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Plural Heterocyclic Compounds (AREA)

JP55044086A 1979-04-06 1980-04-05 フェノチアジン誘導体及びそれらの製造方法 Expired JPS6043345B2 (ja)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
HU79GO1442A HU179190B (en)	1979-04-06	1979-04-06	Process for preparing new phenthiazine derivatives
HU1422		1979-04-06

Publications (2)

Publication Number	Publication Date
JPS55153776A JPS55153776A (en)	1980-11-29
JPS6043345B2 true JPS6043345B2 (ja)	1985-09-27

Family

ID=10996889

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
JP55044086A Expired JPS6043345B2 (ja)	1979-04-06	1980-04-05	フェノチアジン誘導体及びそれらの製造方法

Country Status (16)

Country	Link
JP (1)	JPS6043345B2 (cs)
AT (1)	AT375355B (cs)
BE (1)	BE882535A (cs)
CA (1)	CA1128940A (cs)
CH (1)	CH643843A5 (cs)
CS (1)	CS214704B2 (cs)
DD (1)	DD150060A5 (cs)
DE (1)	DE3013502C2 (cs)
ES (1)	ES8103077A1 (cs)
FR (1)	FR2453164A1 (cs)
GB (1)	GB2047694B (cs)
HU (1)	HU179190B (cs)
IT (1)	IT1148812B (cs)
PL (1)	PL127329B1 (cs)
SU (1)	SU925250A3 (cs)
YU (1)	YU42663B (cs)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH0568560U (ja) *	1991-11-05	1993-09-17	理照大島	握力強化用具

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4471116A (en) *	1982-07-28	1984-09-11	Hoffmann-La Roche Inc.	Substituted (10H-phenothiazin-10-L)-propyl-1-piperazines
JP3932785B2 (ja)	1999-08-25	2007-06-20	株式会社村田製作所	圧電体の製造方法
RU2167157C1 (ru) *	2000-02-11	2001-05-20	Государственный научный центр РФ "НИОПИК"	Способ получения 2-трифторметил-10-(3-хлорпропил)-фенотиазина
US20060111346A1 (en) *	2004-11-23	2006-05-25	Fazix Corporation.	Methods of modulating high-density lipoprotein cholesterol levels and pharmaceutical formulations for the same
EP4447129B1 (en)	2023-04-15	2025-04-23	ML SYSTEM Spólka Akcyjna	Laminar layered photovoltaic panel and method for manufacturing thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NL120362C (cs) *	1961-04-26

1979
- 1979-04-06 HU HU79GO1442A patent/HU179190B/hu not_active IP Right Cessation
1980
- 1980-03-31 GB GB8010794A patent/GB2047694B/en not_active Expired
- 1980-03-31 BE BE1/9766A patent/BE882535A/fr not_active IP Right Cessation
- 1980-04-01 FR FR8007313A patent/FR2453164A1/fr active Granted
- 1980-04-03 CA CA349,181A patent/CA1128940A/en not_active Expired
- 1980-04-03 AT AT0184080A patent/AT375355B/de not_active IP Right Cessation
- 1980-04-03 DD DD80220206A patent/DD150060A5/de not_active IP Right Cessation
- 1980-04-03 CH CH266180A patent/CH643843A5/de not_active IP Right Cessation
- 1980-04-04 IT IT21186/80A patent/IT1148812B/it active
- 1980-04-04 PL PL1980223267A patent/PL127329B1/pl unknown
- 1980-04-04 CS CS802359A patent/CS214704B2/cs unknown
- 1980-04-04 YU YU933/80A patent/YU42663B/xx unknown
- 1980-04-04 SU SU802903447A patent/SU925250A3/ru active
- 1980-04-05 JP JP55044086A patent/JPS6043345B2/ja not_active Expired
- 1980-04-07 ES ES490315A patent/ES8103077A1/es not_active Expired
- 1980-04-08 DE DE3013502A patent/DE3013502C2/de not_active Expired

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH0568560U (ja) *	1991-11-05	1993-09-17	理照大島	握力強化用具

Also Published As

Publication number	Publication date
FR2453164A1 (fr)	1980-10-31
GB2047694A (en)	1980-12-03
DE3013502C2 (de)	1985-02-07
PL127329B1 (en)	1983-10-31
ATA184080A (de)	1983-12-15
GB2047694B (en)	1983-02-02
CA1128940A (en)	1982-08-03
ES490315A0 (es)	1981-02-16
PL223267A1 (cs)	1981-01-30
AT375355B (de)	1984-07-25
BE882535A (fr)	1980-09-30
FR2453164B1 (cs)	1983-04-15
DE3013502A1 (de)	1980-10-16
YU42663B (en)	1988-10-31
JPS55153776A (en)	1980-11-29
DD150060A5 (de)	1981-08-12
IT8021186A0 (it)	1980-04-04
ES8103077A1 (es)	1981-02-16
IT1148812B (it)	1986-12-03
YU93380A (en)	1983-01-21
HU179190B (en)	1982-09-28
CH643843A5 (de)	1984-06-29
SU925250A3 (ru)	1982-04-30
CS214704B2 (en)	1982-05-28

Publication	Publication Date	Title
US3385886A (en)	1968-05-28	Phenyl propionic acids
US4278680A (en)	1981-07-14	Hypoglycaemically and hypolipidaemically active derivatives of phenylacetic acid
HRP20020177A2 (en)	2004-02-29	Sulfonyl carboxamide derivatives, method for their production and their use as medicaments
JPH09512798A (ja)	1997-12-22	消炎、鎮痛および抗血栓活性を有するニトロ化合物およびそれらの組成物
JPS58194814A (ja)	1983-11-12	免疫調節作用を有する薬剤
JPS6043345B2 (ja)	1985-09-27	フェノチアジン誘導体及びそれらの製造方法
JPH05221980A (ja)	1993-08-31	アセチレン化合物
FR2521992A1 (fr)	1983-08-26	Nouveaux composes de pyridine utiles comme medicaments
EP0051514B1 (fr)	1983-11-23	Dérivé d'acide cinnamoyl-cinnamique, son procédé de préparation et son application en thérapeutique
DE3752272T2 (de)	1999-12-30	Verwendung eines Thioesters zur Herstellung von pharmazeutischen Zusammensetzungen zur Behandlung von Ischämie und von Reperfusion-Syndromen
US4067998A (en)	1978-01-10	2-((3,5-Di-tert-butylphenyl)thio) alkanoic acids and derivatives
US5196567A (en)	1993-03-23	Biphenylylpropionic acid derivative, process for preparing the same and pharmaceutical composition containing the same
FR2550091A1 (fr)	1985-02-08	Composition pharmaceutique ou veterinaire destinee a combattre des troubles ischemiques cardiaques contenant un derive du benzofuranne
US3466372A (en)	1969-09-09	Treatment of inflammation with 4-phenyl - alpha - methyl - phenyl acetic acid,its salts,esters or amide derivatives
US3766245A (en)	1973-10-16	3,5-dialkoxyalkoxy-4-substituted benzoic acid esters
AU1359692A (en)	1992-10-21	N-((4,5-dihydroxy- and 4,5,8-trihydroxy-9,10-dihydro-9,10-dioxo-2-anthracene-yl) carbonyl)amino acids useful in the therapy of osteoarticular affections
JPS63190870A (ja)	1988-08-08	抗菌活性を有する化合物、その製造法及びそれを含む医薬製剤
JPH08501557A (ja)	1996-02-20	Ａｃａｔ阻害剤としての１，２−二置換エチルアミド
US4139621A (en)	1979-02-13	N-(4-substituted-3,5-dichloro-phenyl)-piperazines
JPH01104064A (ja)	1989-04-21	塩基性に置換されたベンゾフランカルボン酸アミド、この化合物の製法及びこれを含有する医薬
US3849572A (en)	1974-11-19	Biphenyleneacetic acid anti-inflammatory agents
US4192883A (en)	1980-03-11	Amides of pyrrolidinoethylamine which can be used in lung therapy
ES2347681T3 (es)	2010-11-03	Agentes para tratar el herpes genital despues de su aparicion.
US3891699A (en)	1975-06-24	Biphenylenealkanoic acids
JP3090211B2 (ja)	2000-09-18	第４級ｎ−ベンジル−ｎ−｛２−〔２−（（１ｓ，５ｓ）−６，６−ジメチルビシクロ〔３．１．１〕−ヘプト−２−イル）エトキシ〕エチル｝モルホリニウム塩を含有する胃保護作用を有する製薬学的調剤およびその製造法

JPS6043345B2 - フェノチアジン誘導体及びそれらの製造方法 - Google Patents

Info

Links

Classifications

Landscapes

Applications Claiming Priority (2)

Publications (2)

Family

ID=10996889

Family Applications (1)

Country Status (16)

Cited By (1)

Families Citing this family (5)

Family Cites Families (1)

Cited By (1)

Also Published As

Similar Documents